On Tuesday, May 6th, real-world data and healthcare analytics company Komodo Health announced that it has partnered with Nasdaq Data to provide financial institutions, including hedge funds and private equity/venture capital firms, with a detailed look into the U.S. healthcare and pharmaceutical industries by using the Nasdaq Medical Claims Insights (NMCI) dataset. NMCI will use healthcare data sourced from Komodo’s Healthcare Map to offer increased insight and ability to track provider trends, disease incidence, patient care, prescribing patterns, and more. The data accessible through NMCI does not include any personal or identifiable patient information.
Chief Revenue Officer of Komodo Health Miles Ennis explained the incredible value that the partnership will bring in the company’s press release, stating, “Our partnership with Nasdaq Data provides market participants with a unique dataset that can sharpen their competitive edge across healthcare-related analysis and investing. [With Komodo’s platform] users are provided with unparalleled breadth, quality, and coverage that can help inform decisions in an increasingly dynamic market.”
Brandon Tepper, Senior Vice President and Global Head of Data at Nasdaq noted, “Komodo’s [platform] combined with our data capabilities and innovation has unlocked a unique dataset that provides an in-depth view into the pharmaceutical and U.S. healthcare industries.”
Komodo Health was founded in 2014 by Arif Nathoo and Web Sun, and operates out of San Francisco, CA, with over 700 employees. The company strives to improve patient care and reduce the burdens of disease through the use of real-world data-driven insights. For more information regarding this announcement, read the full press release below.
See related materials: